The collapse of the F126 frigate project in June sent Rheinmetall’s shares into a tailspin, wiping out more than a third of their value from the start of the year. The stock hit a 52-week low of €902.50 on 25 June, a world away from the September record of €1,995.00. Now, less than two weeks later, the shares have clawed their way back above the psychologically important €1,000 mark, closing at €1,036.20 — a daily gain of 3.23%. But the recovery feels fragile, and the road ahead is lined with both opportunity and structural risk.
The immediate catalyst for the rebound is a new artillery contract from Ukraine, announced just days after the F126 shock. Rheinmetall will supply low five-figure rounds and propelling charges, valued in the high double-digit millions of euros, from its Expal plant in Spain. Deliveries run until early 2027, and crucially, the order will be booked in the second quarter of 2026 — a period for which management had already promised stronger order momentum. The deal underscores that demand for conventional shells remains robust, even as the battlefield evolves.
Yet the F126 cancellation has forced Rheinmetall to rethink its strategy. Rather than doubling down on purely national mega-projects, the company is pivoting toward a transatlantic model. Talks are under way to license-produce Tomahawk cruise missiles and PAC-3 interceptor missiles on German soil, effectively turning the group into an industrial bridgehead for US technology in Europe. This shift aligns with the broader political direction: NATO Secretary-General Mark Rutte recently praised Germany’s goal of spending 3.5% of GDP on defence by 2029, lending official weight to the long-term procurement narrative.
Should investors sell immediately? Or is it worth buying Rheinmetall?
Despite this strategic repositioning, the market remains skeptical about Rheinmetall’s ability to defend its margins in a world where cheap FPV drones are increasingly replacing expensive artillery shells. The company’s artillery pipeline is bulging — 155mm munition capacity is set to reach 1.1 million rounds by 2027, and the overall group backlog stood at €73 billion at the end of the first quarter, with the munitions segment alone accounting for €25.8 billion. But the drone threat is structural, not cyclical, and the share price has yet to price in a convincing answer.
Technically, the stock is showing signs of exhaustion rather than a clear trend reversal. The relative strength index sits at 38.9, approaching but not yet in oversold territory. Annualised volatility remains elevated at 66.66%, and the shares trade 33% below their 200-day moving average. The bounce above €1,000 feels like a snap-back driven by bargain hunters betting on a floor, not a sustained shift in sentiment. Since the start of the year, the stock has lost 35.3% of its value.
All eyes now turn to the second-quarter numbers, due later this year, which must deliver on the promised increase in order intake and convert a record backlog into stable margins. Rheinmetall has guided for 2026 revenue of up to €14.5 billion and an operating margin of roughly 19%. After two years of euphoria that carried the stock to nearly €2,000, the market is no longer handing out credit in advance. The next few quarters will determine whether the company can turn its strategic pivot and Ukraine orders into a credible earnings story — or whether the F126 shock was just the first sign of a deeper reassessment.
Ad
Rheinmetall Stock: Buy or Sell?! New Rheinmetall Analysis from July 1 delivers the answer:
The latest Rheinmetall figures speak for themselves: Urgent action needed for Rheinmetall investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 1.
Rheinmetall: Buy or sell? Read more here...
